Women's Health

  • Reproductive issues and multiple sclerosis: 20 questions
    Alise K. Carlson, MD, Daniel Ontaneda, MD, PhD, Mary R. Rensel, MD, Jeffrey A. Cohen, MD and Amy Kunchok, MD
    Cleveland Clinic Journal of Medicine April 2023, 90 (4) 235-243; DOI: https://doi.org/10.3949/ccjm.90a.22066

    The authors offer answers to frequently asked questions about the management of MS during pregnancy planning, pregnancy, and the postpartum period.

  • To repeat or not to repeat? Measuring bone mineral density during anti-resorptive therapy or a drug holiday
    Tayyab S. Khan, MD, Partha Sinha, MD, PhD and Harold Rosen, MD
    Cleveland Clinic Journal of Medicine March 2023, 90 (3) 173-180; DOI: https://doi.org/10.3949/ccjm.90a.22071

    The authors present evidence for and against monitoring bone mineral density in these patients, arguing against a one-size-fits-all approach.

  • Update on current contraceptive options: A case-based discussion of efficacy, eligibility, and use
    Update on current contraceptive options: A case-based discussion of efficacy, eligibility, and use
    Alexa Nicole Fiffick, DO, MBS, NCMP, Tara K. Iyer, MD, NCMP, Tiffany Cochran, MD, MA, NCMP and Pelin Batur, MD, FACP, NCMP
    Cleveland Clinic Journal of Medicine March 2023, 90 (3) 181-190; DOI: https://doi.org/10.3949/ccjm.90a.22075

    Rates of unintended pregnancy are high in the United States. Clinicians need to be well-informed about the full spectrum of contraceptive options to improve reproductive autonomy.

  • Vitamin D: A metabolic bone disease perspective
    Bruce Long, MD, FACR, BS Pharm
    Cleveland Clinic Journal of Medicine February 2023, 90 (2) 91-92; DOI: https://doi.org/10.3949/ccjm.90a.22086

    When checking levels, clinicians should keep in mind that vitamin D levels fluctuate by season and time of day, and that different laboratories may use different assays that yield different results.

  • Bone turnover markers to monitor oral bisphosphonate therapy
    Nikita Ashcherkin, MD, Archna A. Patel, MD, MPH, Alicia Algeciras-Schimnich, PhD and Krupa B. Doshi, MD, FACE
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 26-31; DOI: https://doi.org/10.3949/ccjm.90a.22002

    Rapid changes in levels of bone turnover markers can be useful in monitoring the effectiveness of therapy and improving adherence to therapy.

  • Making best use of bone turnover markers to monitor oral bisphosphonate therapy
    Sarah Keller, MD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 32-34; DOI: https://doi.org/10.3949/ccjm.90a.22092

    Clinical applications of bone turnover markers can include determining when to start or end a bisphosphonate “holiday” and measuring treatment response.

  • Reducing the risk of breast cancer
    Holly J. Pederson, MD, Zahraa Al-Hilli, MD and Allison W. Kurian, MD
    Cleveland Clinic Journal of Medicine November 2022, 89 (11) 643-652; DOI: https://doi.org/10.3949/ccjm.89a.21113

    Breast cancer remains the most common malignancy in US women. Reducing this burden involves identification of high-risk individuals and personalized risk management.

  • What are the considerations in patient selection and timing of risk-reducing mastectomy?
    Holly J. Pederson, MD, Allison W. Kurian, MD, MSc and Zahraa Al Hilli, MD
    Cleveland Clinic Journal of Medicine August 2022, 89 (8) 442-444; DOI: https://doi.org/10.3949/ccjm.89a.21114

    The option of risk-reducing mastectomy is for those at highest risk, and multidisciplinary conversations setting patient expectations are critical for optimal patient outcomes.

  • Mondor disease of the breast
    Toshiyuki Yamaguchi, MD
    Cleveland Clinic Journal of Medicine July 2022, 89 (7) 371-372; DOI: https://doi.org/10.3949/ccjm.89a.21097

    A 43-year-old woman had 2 weeks of pain and skin tightness over the right breast. Ultrasonography revealed a noncompressible, dilated, subcutaneous vein without flow.

  • Women’s health update: A literature review impacting primary care
    Brigid M. Dolan, MD, MEd, Sarah Merriam, MD, MS, Christine A. Prifti, MD and Judith M. Walsh, MD, MPH
    Cleveland Clinic Journal of Medicine July 2022, 89 (7) 373-381; DOI: https://doi.org/10.3949/ccjm.89a.21123

    The authors review cardiovascular disease, bone health, breast cancer risk, cervical cancer prevention, postpartum depression, pelvic pain, and emergency contraception.

Pages